Projected Earnings Date: 2025-01-22    (Delayed quote data   2025-01-06)
Last
 235.10
Change
 ⇑ +3.39   (+1.46%)
Volume
  793,784
Open
 231.95
High
 237.25
Low
 231.18
8EMA (Daily)
 232.39
40EMA (Daily)
 237.85
50EMA (Daily)
 238.13
STO (Daily)
 28.426
MACD Hist (Daily)
 -0.242
8EMA (Weekly)
 237.133
40EMA (Weekly)
 225.59
50EMA (Weekly)
 221.70
STO (Weekly)
 24.885
MACD Hist (Weekly)
 -5.365
ResMed is one of the largest global respiratory medical devices companies, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns 65% of revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com